Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals. 2019

Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.

Osteogenesis imperfecta (OI) is characterized by susceptibility to bone fractures. Other symptoms, such as easy bruising and bleeding complications during surgery necessitating transfusions, have also been reported. The aim of the cross-sectional pilot study was to assess the bleeding and bruising tendency in OI patients and to screen for possible underlying haematological disorders. Bleeding tendency was investigated using the International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH-BAT) in 22 adult OI patients. Laboratory testing was performed to investigate for bleeding disorders or abnormal coagulation. Four patients [OI type 1(n = 3), OI type 4(n = 1)] had a bleeding score (BS) fitting with a bleeding tendency, but without test results pointing to a coagulopathy. Two patients [OI type 1(n = 1), OI type 3 (n = 1)] without a bleeding tendency according to the BS had increased fibrinolysis. This is the second largest study to date addressing bleeding tendency in OI and the first study to use ISTH-BAT and elaborate laboratory testing for coagulopathies. Four patients had an increased bleeding tendency. However, laboratory testing demonstrated no bleeding disorder or abnormal coagulation. Increased fibrinolysis was demonstrated in two patients without bleeding tendency on BS. Vascular fragility as a cause of bleeding tendency in OI has been suggested earlier. Further research on bleeding tendency in OI is important.

UI MeSH Term Description Entries
D008297 Male Males
D010013 Osteogenesis Imperfecta COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I. Fragilitas Ossium,Lobstein Disease,Brittle Bone Disease,Lobstein's Disease,Osteogenesis Imperfecta Tarda,Osteogenesis Imperfecta with Blue Sclerae,Osteogenesis Imperfecta, Type 1,Osteogenesis Imperfecta, Type I,Disease, Lobstein,Disease, Lobstein's,Lobsteins Disease,Ossiums, Fragilitas,Osteogenesis Imperfecta Tardas
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D003288 Contusions Injuries resulting in hemorrhage, usually manifested in the skin. Bruise,Bruises,Contusion
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
February 2023, Research and practice in thrombosis and haemostasis,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
July 2021, European journal of haematology,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
July 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
January 2023, The Turkish journal of pediatrics,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
November 2019, Journal of thrombosis and haemostasis : JTH,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
August 2023, The Lancet. Haematology,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
September 2022, The Lancet. Haematology,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
July 2021, Journal of thrombosis and haemostasis : JTH,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
September 2020, The Lancet. Haematology,
Koert Gooijer, and Jan M M Rondeel, and Fleur S van Dijk, and Arjan G J Harsevoort, and Guus J M Janus, and Anton A M Franken
September 2017, The Lancet. Haematology,
Copied contents to your clipboard!